-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Like all viruses, the human immunodeficiency virus (HIV) cannot replicate on its own
To achieve this, the scientists used CRISPR-Cas9 gene editing to create a functional map of the interaction between HIV and human T cells
The researchers believe this study opens the door to exploring these interactions and ultimately developing new drugs that block them
Co-corresponding author Dr Judd Hultquist said: "Existing antiviral drugs have shown promising results in reducing HIV replication in the body, but these drugs have some drawbacks, including the need for people to take them for life
In this study, the researchers focused on the interactions between proteins
"This allows us to map very specifically how HIV interacts with these human proteins," said co-first author Joseph Hiatt of UCSF
Investigators have devoted more than six months to the project
"Over the past two years, the world has focused on the COVID-19 pandemic, while other pandemics have faded from view," Hultquist said
Original text retrieval
Hiatt, J.
